home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
The Arsenal Files 6
/
The Arsenal Files 6 (Arsenal Computer).ISO
/
health
/
med9604b.zip
/
M9640665.TXT
< prev
next >
Wrap
Text File
|
1996-03-04
|
3KB
|
53 lines
Document 0665
DOCN M9640665
TI Natural history of somatic growth in infants born to women infected by
human immunodeficiency virus. Women and Infants Transmission Study
Group.
DT 9604
AU Moye J Jr; Rich KC; Kalish LA; Sheon AR; Diaz C; Cooper ER; Pitt J;
Handelsman E; Pediatric, Adolescent, and Maternal AIDS Branch, National;
Institute of Child Health and Human Development, National; Institutes of
Health, Bethesda, MD 20892-7510, USA.
SO J Pediatr. 1996 Jan;128(1):58-69. Unique Identifier : AIDSLINE
MED/96144595
AB OBJECTIVE: To evaluate the nature and magnitude of the effect of
congenitally or perinatally acquired human immunodeficiency virus (HIV)
infection on somatic growth from birth through 18 months of age. STUDY
DESIGN: Anthropometry was performed serially in 282 term infants born to
HIV-infected women in a multicenter prospective natural history cohort
study. Repeated measures analysis was used to compare z-score
anthropometric indexes of weight-for-age, length-for-age,
weight-for-length, and head circumference-for-age between infected and
uninfected infants, with adjustment for covariates including infant
gender; maternal education; prenatal alcohol, tobacco, and/or illicit
drug exposure; and mean prenatal CD4+ T-lymphocyte count. A separate
repeated measures model was used to assess the effect of infant
zidovudine treatment on growth. RESULTS: Infants infected with HIV were
an estimated average 0.28 kg lighter and 1.64 cm shorter than uninfected
infants at birth, were 0.71 kg lighter and 2.25 cm shorter by 18 months
of age, and had a sustained estimated average decrement of 0.70 to 0.75
cm in head circumference. Patterns of growth were similar in male and
female infants. Infected infants had a progressive decrement in body
mass index from birth through 6 months of age. Infection with HIV was
associated with significant decrements across all standardized growth
outcome measures after adjustment for covariates. Mean z scores were
lower for weight by 0.612 (p < 0.001), for length by 0.735 (p < 0.001),
for weight-for-length by 0.255 (p = 0.02), and for head circumference by
0.563 (p < 0.001) SD units compared with uninfected infants. Zidovudine
treatment was not associated with improved growth. CONCLUSION: The
effect of congenitally or perinatally acquired HIV infection on infant
growth is one of early and progressive decrements in attained linear
growth and growth in mass, early and sustained decrements in head
growth, and marked early decrements in body mass index.
DE Body Height/PHYSIOLOGY Body Weight/PHYSIOLOGY Disease Transmission,
Vertical Female Growth/*PHYSIOLOGY Head/GROWTH & DEVELOPMENT Human
HIV Infections/CONGENITAL/DRUG THERAPY/*PHYSIOPATHOLOGY/ TRANSMISSION
Infant Infant, Newborn Male Multivariate Analysis Pregnancy
*Pregnancy Complications, Infectious Prospective Studies Support, U.S.
Gov't, P.H.S. Zidovudine/THERAPEUTIC USE JOURNAL ARTICLE MULTICENTER
STUDY
SOURCE: National Library of Medicine. NOTICE: This material may be
protected by Copyright Law (Title 17, U.S.Code).